Microvascular Angina: Clinical Trials

5 trials for Microvascular Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 22Recruiting 1, Unknown 1

Follow Microvascular Angina: new trials by email Literature Review of Microvascular Angina trials Research Report on Microvascular Angina

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebivolol ANOCA Treatment Randomized Trial
Nevibolol, Placebo - ANOCA - Angina With Non-obstructive Coronary Arteries, Coronary Microvascular Dysfunction (CMD)
Phase 3Not yet recruitingSpanish Society of Cardiology1502025-04-012025-01-01
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Amlodipine, Nebivolol, Placebo - Angina Pectoris, Microvascular Angina
Phase 2 / Phase 3RecruitingStanford University1502024-10-102024-11-27
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
Prednisolone, Losartan - COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle
Phase 3Active not recruitingValentina Puentmann2792022-12-122025-12-09
Rhodiola Rosea for Coronary Microvascular Disease
Rhodiola Rosea Capsules, Placebo - Coronary Microvascular Disease
Phase 2 / Phase 3UnknownQilu Hospital of Shandong University1142020-01-012020-01-06
Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
Diltiazem Hydrochloride, Placebo - Microvascular Angina, Coronary Vasospasm
Phase 3Active not recruitingRadboud University Medical Center852019-10-252023-03-30

Narrower conditions

Angina Pectoris (2)  ·  Angina Pectoris, Variant (1)  ·  Coronary Vasospasm (1)  ·  Myocarditis (1)  ·  Pericarditis (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Vascular Remodeling (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Remodeling (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Heart Diseases (5)  ·  Myocardial Ischemia (5)  ·  Vascular Diseases (5)  ·  Angina Pectoris (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Chest Pain (2)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Signs and Symptoms (2)  ·  Angina, Unstable (1)  ·  COVID-19 (1)  ·  Cardiomyopathies (1)  ·  Chronic Disease (1)  ·  Coronary Disease (1)

Interventions

Amlodipine (1)  ·  Diltiazem (1)  ·  Losartan (1)  ·  Nebivolol (1)  ·  Prednisolone (1)

Sponsors

Qilu Hospital of Shandong University (1)  ·  Radboud University Medical Center (1)  ·  Spanish Society of Cardiology (1)  ·  Stanford University (1)  ·  Valentina Puentmann (1)

Countries

Austria (1)  ·  Germany (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Eike Nagel, MD, PhD (1)  ·  Jennifer Tremmel, MD (1)  ·  Suzette Elias-Smale, MD, PhD (1)  ·  Valentina Puntmann, MD, PhD (1)

Results publications

PMID 35466050, PMID 37889203, PMID 42533000

NIH funding

2018 (1)